Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Cash & Current Investments (2016 - 2026)

Integra Lifesciences Holdings' Cash & Current Investments history spans 17 years, with the latest figure at $263.7 million for Q4 2025.

  • On a quarterly basis, Cash & Current Investments fell 3.59% to $263.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $263.7 million, a 3.59% decrease, with the full-year FY2025 number at $263.7 million, down 3.59% from a year prior.
  • Cash & Current Investments hit $263.7 million in Q4 2025 for Integra Lifesciences Holdings, down from $267.9 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for IART hit a ceiling of $663.1 million in Q1 2024 and a floor of $253.6 million in Q2 2025.
  • Historically, Cash & Current Investments has averaged $369.1 million across 5 years, with a median of $309.1 million in 2023.
  • Biggest five-year swings in Cash & Current Investments: surged 115.74% in 2024 and later plummeted 58.79% in 2025.
  • Tracing IART's Cash & Current Investments over 5 years: stood at $513.4 million in 2021, then dropped by 11.06% to $456.7 million in 2022, then tumbled by 32.31% to $309.1 million in 2023, then fell by 11.5% to $273.6 million in 2024, then dropped by 3.59% to $263.7 million in 2025.
  • Business Quant data shows Cash & Current Investments for IART at $263.7 million in Q4 2025, $267.9 million in Q3 2025, and $253.6 million in Q2 2025.